...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >THE EFFECT OF NECITUMUMAB IN COMBINATION WITH GEMCITABINECISPLATIN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND TOLERABILITY: SQUIRE TRIAL PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-EXPRESSING SQUAMOUS NSCLC TUMOURS

【24h】

THE EFFECT OF NECITUMUMAB IN COMBINATION WITH GEMCITABINECISPLATIN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND TOLERABILITY: SQUIRE TRIAL PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-EXPRESSING SQUAMOUS NSCLC TUMOURS

机译：尼西妥单抗联合吉西他滨对生命质量（HRQOL）和耐受性的健康相关性：表皮生长因子受体（EGFR）表达的鳞状NSCLC肿瘤患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research 》 |2016年第7期| 共2页
作者
Reck M.; Socinski M.; Szczesna A.; Dediu M.; Ramlau R.; Losonczy G.; Molinier O.; Schumann C.; Brown J.; Soldatenkova V; Chouaki N.; Thatcher N.; Luft A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学 ;
关键词

相似文献

外文文献
中文文献
专利

1. THE EFFECT OF NECITUMUMAB IN COMBINATION WITH GEMCITABINECISPLATIN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND TOLERABILITY: SQUIRE TRIAL PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-EXPRESSING SQUAMOUS NSCLC TUMOURS [J] . Reck M., Socinski M., Szczesna A., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016 ,第7期

机译：尼西妥单抗联合吉西他滨对生命质量（HRQOL）和耐受性的健康相关性：表皮生长因子受体（EGFR）表达的鳞状NSCLC肿瘤患者
2. 54LBA High coexpression of both the insulin-like growth factor receptor-1 (IGF-1R) and epidermal growth factor receptor (EGFR) correlates with a poor patient prognosis in resected non-small cell lung cancer (NSCLC) [J] . K.Gately, L.Forde, S.Cuffe, European Journal of Cancer Supplements . 2009 ,第3期

机译：54LBA胰岛素样生长因子受体1（IGF-1R）和表皮生长因子受体（EGFR）的高共表达与切除的非小细胞肺癌（NSCLC）患者预后差有关
3. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC). [J] . Kollmannsberger C, Schittenhelm M, Honecker F, Annals of oncology: official journal of the European Society for Medical Oncology . 2006 ,第6期

机译：人源化单克隆抗表皮生长因子受体（EGFR）抗体EMD 72000（matuzumab）与紫杉醇联合用于EGFR阳性晚期非小细胞肺癌（NSCLC）患者的I期研究。
4. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery [C] . Xiaochun Xu, Kimberley S Samkoe, Eric R. Henderson Society of Photo-Optical Instrumentation Engineers;Conference on Molecular-Guided Surgery: Molecules, Devices, and Applications . 2020

机译：术前癌症治疗对ABY-029导向肉瘤手术中表皮生长因子受体（EGFR）受体表达水平的影响
5. Epidermal growth factor receptor (EGFR) gene expression and its related biomarkers in head and neck squamous cell carcinoma (HNSCC) [D] . Hauser, Belinda R. 2008

机译：表皮生长因子受体（EGFR）基因表达及其相关的生物标志物在头颈部鳞状细胞癌（HNSCC）中
6. Editors choice: Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized multicenter open-label phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer [O] . L. Paz-Ares, M. A. Socinski, J. Shahidi, -1

机译：编辑选择：SQUIRE中EGFR表达与安全性和疗效结果的相关性：吉西他滨-顺铂加尼妥单抗与单独吉西他滨-顺铂在IV期患者一线治疗中的随机多中心开放标签III期研究鳞状非小细胞肺癌
7. 1320_PR: Subgroup analyses of patients with epidermal growth factor receptor (EGFR)-expressing tumors in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin (GC) plus necitumumab (N) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC) [O] . L. Paz-Ares, M.A. Socinski, J. Shahidi, 2016

机译：1320_pr：表皮生长因子受体（EGFR）患者的亚群分析 - 表达肿瘤患者：一种随机，多中心，开放标签，吉西拜齐铂（GC）加上Necitumumab（N）对GC的第一个研究阶段鳞状非小细胞肺癌（SQ-NSCLC）的患者（PTS）治疗患者（PTS）治疗
8. Regulation of Epidermal Growth Factor Receptor (EGFR) Expression by PML in HumanBreast Cancer [R] . Chin, K. V. 1995

机译：pmL对人乳腺癌中表皮生长因子受体（EGFR）表达的调节作用

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号